Insight Molecular Diagnostics (IMDX) Investor presentation summary

Mission and vision

• Aims to decentralize access to novel molecular diagnostic testing to improve patient outcomes.

• Focuses on empowering local labs to perform in-house testing with kits, reducing reliance on central labs.

• Seeks to enable rapid, personalized, and localized care through genomics innovation.

Leadership and team

• Led by a science-driven team with deep experience in molecular diagnostics and rapid growth management.

• Leadership includes experts from major biotech and diagnostics companies.

Product portfolio and innovation

• Offers a full R&D pipeline supporting portfolio expansion for the next decade.

• Flagship product GraftAssureDx targets decentralized transplant monitoring, with expansion plans into heart transplant testing.

• Kits are designed for ease of use, fast turnaround, and clinical actionability.